Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes

Cancer Immunology, Immunotherapy

Volumn 49, Issue 11, 2001, Pages 593-602

  Van Pel, Aline Van ^a   De Plaen, Etienne ^a   Duffour, Marie Therese ^b,c   Warnier, Guy ^a   Uyttenhove, Catherine ^a   Perricaudet, Michel ^b   Boon, Thierry ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Immuno Design Molecules   (France)

Author keywords

Adenovirus; Antigen; Cytotoxic T lymphocytes; Mouse; Tumor immunity

Indexed keywords

GENE PRODUCT; MAGE ANTIGEN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; TUMOR REGRESSION; VIRUS RECOMBINANT;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; H-2 ANTIGENS; HUMANS; IMMUNIZATION; MASTOCYTOSIS; MICE; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034466493     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000141     Document Type: Article

References (52)

1. Interleukin-2-induced, melanoma-specific T cells recognize camel, an unexpected translation product of LAGE-1
2. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
3. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis
4. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815
5. Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures
6. The dual nature of specific immunological activity of tumor-derived gp 96 preparations
7. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
8. A family of rapidly evolving genes from the sex reversal critical region in Xp21
9. Structure, chromosomal localization and expression of twelve genes of the MAGE family
10. A new family of mouse genes homologous to the human MAGE genes
11. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
12. A novel and simple procedure for determining T cell epitopes in protein antigens
13. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration
14. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
15. Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells
16. Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12
17. Thymoma production of T cell growth factor (interleukin 2)
18. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
19. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53
20. LAGE-1, a new gene with tumor specificity
21. Mouse tumor rejection antigens P815A and P815B:Two epitopes carried by a single peptide
22. MAGE-B5, MAGE-B6, MAGE-C2 and MAGE-C3: Four new members of the MAGE family with tumor-specific expression
23. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
24. Two members of the human MAGEB gene family located in Xp.21.3 are expressed in tumors of various histological origins
25. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
26. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones
27. Non-traditionally derived CTL epitopes: Exceptions that prove the rules?
28. Malaria vaccine: Immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity
29. Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice
30. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
31. Isolation and characterization of a new MAGE gene family in the Xp21.3 region
32. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
33. Regulation of expression of genes transduced into embryonal carcinoma cells
34. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28
35. - transplantation antigen P198: A point mutation generates a new antigenic peptide
36. Enhancement by IL-12 of CTL response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL
37. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
38. Widespread long-term gene transfer to mouse skeletal muscles and heart
39. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
40. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes
41. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen
42. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression
43. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice
44. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
45. A new antigen recognized by cytolytic T lymphocytes on a human kidney results from reverse strand transcription
46. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
47. Selection of a highly transfectable variant from mouse mastocytoma P815
48. A breast and melanomashared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames
49. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen
50. Induction of a cytolytic T cell response in mice with a recombinant adenovirus coding for tumor antigen P815A
51. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides
52. Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay